home / stock / celuw / celuw news

CELUW News and Press, Celularity Inc. Warrant From 06/10/25

Stock Information
Company Name: Celularity Inc. Warrant
Stock Symbol: CELUW
Market: NASDAQ
Website: celularity.com
Menu
CELUW CELUW Quote CELUW Short CELUW News CELUW Articles CELUW Message Board
Get CELUW Alerts

News, Short Squeeze, Breakout and More Instantly...
CELUW - Celularity Announces Chief Financial Officer Transition

FLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (“CFO”), D...
CELUW - Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology

Highlights the unique potential of Celularity’s proprietary advanced biomaterial technology as a novel cellular delivery system for ocular surface reconstruction Supports broad range of regenerative medicine applications beyond ophthalmology FLORHAM PARK, N.J., June 02, 2025 (G...

CELUW - Celularity notified of Nasdaq non-compliance

2025-05-30 17:36:43 ET More on SHYD - Perfectly Adequate, Just Not Good Enough I Think EOG Resources: Quality Energy Player Makes A Quality Move Lam Research: I Love The Innovation, But Dislike The Stock Valuation CoStar Group and Happening settle dispute ...

CELUW - Celularity Receives Nasdaq Notice Regarding Form 10-Q

FLORHAM PARK, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that on May 28, 2025, Nasdaq notified the Company that it did not timely file its Quarterl...
CELUW - Celularity Announces Full Year 2024 Operating and Financial Results

FLORHAM PARK, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced operating and financial results for the year ended December 31, 2024. “We built...

CELUW - Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees

FLORHAM PARK, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that Nasdaq has notified the Company that it has not paid certain fees required by Listi...

CELUW - Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products

FLORHAM PARK, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 202...
CELUW - Celularity Announces Publication of "Senescence, NK cells, and cancer: navigating the crossroads of aging and disease" in the April 4, 2025, Issue of Frontiers in Immunology

FLORHAM PARK, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced a key publication in the April 4, 2025, issue of the prestigious peer-reviewed journal ...

CELUW - Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft(TM) Wound Care Products

FLORHAM PARK, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that on December 19, 2024, it received recommendation letters from the US Food and Drug A...

CELUW - Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company

FLORHAM PARK, N.J., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a cellular and regenerative medicine company, today announced that it has entered into a Master Services Collaboration Agreement with BlueSphere Bio, I...
Previous 10 Next 10